Matinas BioPharma (MTNB)

• Market cap: $3.78M
• 1 day: -1.73%
• 5 days: -14.48%
• 1 month: -8.08%
• 3 months: -55.96%
• 6 months: -38.53%
• Year to date: -4.82%
• 1 year: 2.8%
• 5 years: -99.02%
• 10 years: -99.69%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Employees: 34